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Abstract
Chrysotherapeutics are under investigation as new or additional treatments for different types of cancers. In
this study, gold complexes were investigated for their anticancer potential using Raman spectroscopy. The aim
of the study was to determine whether Raman spectroscopy could be used for the characterization of
metallodrug-induced cell death. Symptoms of cell death such as decreased peak intensities of proteins bonds
and phosphodiester bonds found in deoxyribose nucleic acids were evident in the principal component
analysis of the spectra. Vibrational bands around 761 cm−1 and 1300 cm−1 (tryptophan, ethanolamine
group, and phosphatidylethanolamine) and 1720 cm−1 (ester bonds associated with phospholipids) appeared
in the Raman spectra of cervical adenocarcinoma (HeLa) cells after metallodrug treatment. The significantly
(p < 0.05, one way analysis of variance) increased intensity of phosphatidylethanolamine after metallodrug
treatment could be a molecular signature of induced apoptosis since both the co-regulated phosphatidylserine
and phosphatidylethanolamine are externalized during cell death. Treated cells had significantly higher levels
of glucose and glycogen vibrational peaks, indicative of a survival mechanism of cancer cells under chemical
stress. Cancer cells excrete chemotherapeutics to improve their chances of survival and utilize glucose to
achieve this. Raman spectroscopy was able to monitor a survival strategy of cancer cells in the form of glucose
uptake to alleviate chemical stress. Raman spectroscopy was invaluable in obtaining molecular information
generated by biomolecules affected by anticancer metallodrug treatments and presents an alternative to less
reproducible, conventional biochemical assays for cytotoxicity analyses.
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characterizable by Raman spectroscopy
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Chrysotherapeutics are under investigation as new or additional treatments for different types of
cancers. In this study, gold complexes were investigated for their anticancer potential using Raman
spectroscopy. The aim of the study was to determine whether Raman spectroscopy could be used
for the characterization of metallodrug-induced cell death. Symptoms of cell death such as
decreased peak intensities of proteins bonds and phosphodiester bonds found in deoxyribose
nucleic acids were evident in the principal component analysis of the spectra. Vibrational bands
around 761 cm1 and 1300 cm1 (tryptophan, ethanolamine group, and phosphatidylethanolamine)
and 1720 cm1 (ester bonds associated with phospholipids) appeared in the Raman spectra of cervi-
cal adenocarcinoma (HeLa) cells after metallodrug treatment. The significantly (p< 0.05, one way
analysis of variance) increased intensity of phosphatidylethanolamine after metallodrug treatment
could be a molecular signature of induced apoptosis since both the co-regulated phosphatidylserine
and phosphatidylethanolamine are externalized during cell death. Treated cells had significantly
higher levels of glucose and glycogen vibrational peaks, indicative of a survival mechanism of can-
cer cells under chemical stress. Cancer cells excrete chemotherapeutics to improve their chances of
survival and utilize glucose to achieve this. Raman spectroscopy was able to monitor a survival
strategy of cancer cells in the form of glucose uptake to alleviate chemical stress. Raman spectros-
copy was invaluable in obtaining molecular information generated by biomolecules affected by
anticancer metallodrug treatments and presents an alternative to less reproducible, conventional
biochemical assays for cytotoxicity analyses. VC 2014 AIP Publishing LLC.
[http://dx.doi.org/10.1063/1.4896616]
Cervical cancer is the second most commonly diagnosed
cancer worldwide among women, with an estimated 530 000
new cases reported annually. Every year approximately
270 000 women die of cervical cancer and >85% of recorded
fatalities are found in low- and middle income countries.1
Cervical cancer is one of the biggest health problems among
South African women, affecting one out of every 41 women
and mortalities associated with this disease are estimated
around eight South African women per day.2 The co-
infection of human immunodeficiency virus (HIV) and
human papillomavirus is well documented.3,4 Advances in
diagnoses/success of highly active antiretroviral therapy lead
to HIV positive patients being diagnosed up to 10 years ear-
lier with advanced stages of cervical cancer. With these stag-
gering statistics in mind, new chemotherapeutic treatments
are under investigation.2
Research into gold based compounds as potential cancer
treatments started in 1980,5 but this metal had been used cen-
turies prior for the treatment of other ailments.6 During the
early phases of metallodrug research, it was found that deriv-
atives containing the linear P–Au–S structure found in aura-
nofin (a known rheumatoid arthritis drug) had potential for
treating cancer.5
Successful cancer treatments are expected to selectively
kill diseased cells only and the cytotoxic effects of the drugs
are routinely monitored by conventional biochemical
assays such as 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide (MTT) reduction assays,7 microscopy,
flow cytometric techniques,8 and real time cell electronic
sensing (RT-CES).9 The disadvantages of some of these tech-
niques are that expensive reagents are needed and specialised
instruments to measure absorbance, impedance, fluorescence,
or luminescence of labelled biosensors. An alternative to these
techniques could be Raman spectroscopy where samples can
be investigated in a label free manner, with minimal prepara-
tion and analyses in relatively short time periods.
In this investigation, gold (I) complexes were investigated
for their cytotoxic effect on a cancer cell line. We suggest
Raman spectroscopy as a practical tool for the characteriza-
tion of chemically induced cell death in a population.
Two organic gold complexes 2-(2-(diphenylphosphino)
ethyl)pyridyl-gold(I) chloride (AE 76) and 2-(diphenyl
phosphino)-20-(N,N-dimethylamino)biphenylgold(I) chloride
(AE125) were synthesized and characterized35,36 by the labo-
ratory of Professor Darkwa in the Chemistry Department of
the University of Johannesburg, South Africa. Details of the
synthesis and characterization can be found in the Ph.D. thesis
of Elkhadir, 2014.37 Auranofin (Sigma, Germany) was used
as a positive control drug for the induction of apoptosis.10,11
Apoptotic cell death induction by the metallodrugs was
determined using flow cytometry. Exponentially growing HeLa
cells were seeded (105 cells/ml) and incubated for 24 h (37 C,
5% CO2) after which the cells were exposed to the metallodrugs
(auranofin¼ 5.6lM, AE76¼ 20.8 lM, and AE125¼ 17.8lM)
for 72 h. After treatment, detached cells were collected and the
a)Author to whom correspondence should be addressed. Electronic mail:
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wells washed with 500ll phosphate buffered saline (PBS). The
cells were rinsed with 200ll trypsin (Hyclone) and incubated
for 5 min. Trypsinized cells were washed twice with the respec-
tive collected media, thus pooling detached and adherent cells.
Pooling cells was capable in this case because the cells were in
various stages of cell death. Samples were prepared for annexin-
V and propidium iodide staining as prescribed by the manufac-
tures (BD Biosciences, California, USA) and analysed using a
fluorescence-activated cell sorter (FACS) Aria. Four independ-
ent experiments were performed and expressed as % cell events
with standard error of the mean. Data were analysed statistically
using one way analysis of variance (ANOVA) where p< 0.05
was documented as significant.
After the quantification of apoptosis (with flow cytome-
try), a qualitative Raman spectroscopic study was done to
determine the molecular changes. The method published by
Matthaus et al.12 was used as a guideline. Cells were prepared
in the same manner as for flow cytometry and pooling cells
which were centrifuged for 10 min at 1200 reps per minute.
The supernatant was discarded, the pellets loosened, and the
cells washed twice with 1 ml PBS. The cells were incubated at
room temperature in 1 ml of 10% formalin for 10 min and
then centrifuged for 5 min. The cells were washed with 1 ml
sterile distilled water and centrifuged to remove all traces of
formalin. The cells were suspended in 10 ll sterile distilled
water. Three microliters cell suspension was dried in the bio-
safety flow hood for 1 h on sterile CaF2 discs. Raman micro-
spectroscopy was performed with a T64000 micro-Raman
spectrometer from HORIBA Scientific. The 514.5 nm line of
an Innova 70v argon-krypton mixed gas laser was used as ex-
citation source. The 50 objective of an Olympus microscope
was used to focus the laser beam (spot size 2 lm) in the
middle of single air-dried cells, where the nuclei is most likely
situated as is the norm.13–16 The laser power at the sample
was kept constant at 10 mW. Three independent experiments
were carried out of which a total of seven cells per treatment
were analysed. All the spectra were recorded with a 150 s ac-
quisition time for two accumulations. The Labspec 6.0 soft-
ware was used to fit and subtract a fourth order polynomial
function to obtain a zero baseline. A 5 degree linear Savitsky-
Golay smoothing procedure was applied to all the spectra.
Second derivatives of the spectra (vector normalized) were
used for final interpretations (generated in OPUS 7). Principal
component analysis (PCA) was carried out using Quant 2
OPUS software. Vibrational peaks of interest involving phos-
pholipid and glucose metabolism were validated with one way
ANOVA followed by Tukey’s multiple comparison test using
GraphPad Prism 5. Changes in vibrational peaks were signifi-
cant if p< 0.05.
The metallodrugs were evaluated using conventional
biochemical methodologies to determine the degree of cyto-
toxicity and the type of cell death induction. Raman spec-
troscopy was then used to identify molecular targets of the
metallodrugs and the drug induced effects on phospholipid
and glucose metabolism. Flow cytometric analysis detected
that early apoptosis was significantly (p< 0.05) induced by
the metallodrugs (Fig. 1).11 Less than 14% of the cells was
viable, confirming light microscopic evidence which indi-
cated that all cells treated with AE 76 and auranofin experi-
enced severe chemical distress after treatment.
Further insight into the mechanism of action of the three
metallodrugs was determined by studying the molecular
vibrations of the chemically stressed cells. The investigation
was focused on the centre of the HeLa cells. This area of
cells are known to be rich in nuclear material such as pro-
teins, lipids, nucleic acids, nuclear membranes, and plasma
membranes.13,15,17 The hallmarks of apoptosis involve the
nucleus (chromatin condensation and deoxyribose nucleic
acids (DNA) fragmentation, etc.18) and are well documented.
The raw spectra of the cells analysed in this study11 had
vibrational peaks for proteins, lipids, nucleic acids, and car-
bohydrates and were comparable to previously reported
spectra obtained for HeLa cells including Raman spectra of
the nucleus.12,16 Since only small variances were seen in
the raw spectra of untreated and metallodrug treated
spectra, second derivatives were used for further discussion
(Fig. 2). The most prominent peaks in the spectra belonged
to protein vibrations, namely, methyl (CH3) stretch vibra-
tions (2927 cm1), amide I at 1657 cm1 (overlapping with
peaks originating from fatty acids including triglycerides),
amide III overlapping with asymmetric phosphate stretching
modes (1224 cm1), phenylalanine (1006 cm1), and tyro-
sine (1165 cm1).19 The intensity of CH2 symmetric stretch
vibrations (2862 cm1) of lipids/proteins19 and carbon-
hydrogen (CH) and CH2 vibrations
19 at 1449 cm1 were also
prominent. Cellular responses to treatment were heterogene-
ous, probably due to different degrees of sensitivity20 of indi-
vidual cells to the treatments. Heterogeneity of the spectra
could also be due to the spectra only being recorded for
the centre of the cell, where nuclear material could be show-
ing different stages of apoptotic progression (chromatin con-
densation would be presented by increased DNA intensities
compared to decreased DNA intensities due to DNA
fragmentation21,22). The cell number was sufficient for this
study,15,21,23,24 since it was qualitative and was carried out
on well-defined populations of viable and apoptotic cells as
determined with flow cytometry.
Focusing on single peaks is not sufficient when describ-
ing the major peak shifts seen in this study which is why
PCA was used for further analysis.13 Cells were not deliber-
ately synchronized but our data (Fig. 3) showed that
FIG. 1. Flow cytometry: The percentages viable and dead HeLa cells after
treatment with different concentrations of metallodrugs. The induction of
early apoptosis was significant (*p< 0.05) for all treatments. Necrotic events
were negligible and late apoptosis was minimal (n¼ 4).
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intercellular variations was low. The occurrence can be
explained by the study of Matthews et al.25 where cells were
mostly in one (gap 1) phase. Score plots were used to iden-
tify significant changes between untreated and treated HeLa
cells. It was found that most of the spectral variance was
within the first PC between the 600–1800 cm1 region. In
the case of PC 1, the untreated cells clustered separately
from the treated cells, with the exception of some of the
spectra of AE 125 treated cells (Fig. 3(a)). This clustering is
explained by the different stages of cellular responses after
treatment. Although all cells were exposed to AE 125 simul-
taneously, the exact amount absorbed may differ so that indi-
vidual cells are at different stages of early apoptosis
allowing some to behave as if unaffected by treatment (as if
untreated), while others present a more severe response.
Flow cytometry showed a population of seemingly healthy
cells migrating towards early apoptosis after cells were
treated with AE 125.11 These trends in cellular responses
were also prominent in the study conducted by Brauchle
et al., which found that Saos-2 and SW-1353 apoptotic cells
(exposure to room temperature for 4 days) also showed poor
separation on PCA score plots.13 In the AE 76 treated cells,
the spectra showed a higher degree of spectral variance
between samples, but all cells behaved as if apoptotic. The
differences in response between treatments are explained by
their structural differences. The many bulky aromatic rings
of AE 125 certainly affect its cellular absorption.
Clustering of untreated and treated HeLa cells showed
strong separation along PC 1. Spectra obtained from metallo-
drug treated cells were associated with negative scores in the
score plot. Since the PCA was performed on second deriva-
tives, a negative score was associated with a positive loading.26
The positive loadings in PC 1 corresponded to a decrease in
tryptophan (750 cm1), phenylalanine (1004 cm1), amide III
(1275 cm1), cytosine (1513 cm1), and a combination of tyro-
sine, tryptophan, and C¼C protein vibrations (1614 cm1)19
and was associated with treated HeLa cells. The positive load-
ings were packed with amino acid, and protein vibrations
decreased as compared to untreated HeLa cells. The negative
loadings in PC 1 corresponded to lipid vibration (968 cm1),
phospholipids and phosphodiester groups of nucleic acids
(1080 cm1), and C¼C, carbonyl (C¼O) (lipids), and amide I
(1653 cm1)19 (Fig 3(b)). The negative loadings were associ-
ated with untreated and some AE125 cells therefore indicative
FIG. 2. The second derivatives of untreated and metallodrug treated HeLa
cells in the regions between (a) 600–1150 cm1, (b) 1150 cm1–1800 cm1,
and (c) 2600–3200 cm1. Major spectral differences are visible which indi-
cate aspects of the mechanism of action of these metallodrugs and also
induction of apoptotic cell death.
FIG. 3. Principal component analysis score plots comparing the second
derivatives of the Raman spectra of (a) the region of 600–1800 cm1, “live”
and less damaged cells, while all others clustered together (dead) and (b)
corresponding loading spectra leading to the clustering in the PCA plot.
Assigned components were identified as major contributors of separation.
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of the other treated cells having lower intensities in some
proteins, phospholipids, and other lipids as well as phosphodi-
ester groups associated with nucleic acids as compared to via-
ble cells. These findings were in agreement with other
researchers.15,21,27 PC 1 explained the highest variance within
the spectra, while some clustering could be seen due to PC 2
loadings. Negative loadings of PC 2 corresponded to cytosine
(669 cm1), phosphatidylethanolamine (761 cm1), lipids
(968 cm1), and amide II (1543 cm1).19 Positive loadings of
PC 2 were DNA (795 cm1), phenylalanine (1004 cm1), car-
bohydrates (1112 cm1), and phenylalanine (1586 cm1).
The decrease of a band at 795 cm1 had been suggested by
previous researchers to be related to internucleosomal DNA
cleavage.13,15,20 Negative loadings of PC 2 were associated
with the increase in glucose (1072 cm1) and glycogen
(1028 cm1), indicating noteworthy changes in the metabolism
of treated cells, which were further investigated to determine
the significance of the metabolites.
Changes in carbohydrate vibrational peaks could give
more insight into the metabolic functions of the treated cells.
Peaks assigned to glycogen was identified in the PCA load-
ings around 853 cm1, 918 cm1, 935 cm1, 1028 cm1,
1155 cm1, and 1335 cm1.19,27–29 The bands at 1028 cm1
and 1155 cm1 significantly (p< 0.05)11 increased in inten-
sity. Together with the peak at 1072 cm1 identified in the
PCA, other glucose and polysaccharides related peaks,
898 cm1 and 920 cm1, were also identified.19 The peak at
1072 cm1 significantly increased. Changes in the intensities
of glycogen or glucose could be indicative of a survival
mechanism of chemically stressed cancer cells. Higher con-
centrations of glucose within the cells could be due to the
active up take of glucose from the nutrient rich culture
media, while the surplus glucose within the cells were stored
as glycogen. Although the apoptotic process had already
started as detected with flow cytometry and Raman spectros-
copy, it is generally known that cancer cells do not die easily
and thus will try to excrete any of the drugs taken up. Energy
to sustain the excretion of the metallodrugs could come from
glucose.
In the PCA, loading plots indicated spectral changes in
phospholipids. Spectral peaks associated with the plasma
membrane were identified and further analysed to determine
significant changes which could be linked to flow cytometry
results. The laser pathway through the cell interrogates the
plasma membrane, cytoplasm, nuclear membranes, and nu-
clear material. The peaks at 733 cm1 and 787 cm1 in spectra
of the untreated cells were assigned to phosphatidylserine.19,30
Phosphatidylserine forms part of the inner leaflet of the
plasma membrane and make up 2%–10% of all the phospholi-
pids found in the plasma membrane.31 During apoptosis, a
conformational change takes place within the bilayer of the
plasma membrane. This conformational change occurs when
phosphatidylserine is externalized on the cellular surface. It
was found that the peaks changed significantly11 in intensity
after treatment. Phosphatidylethanolamine (761 cm1 and
1300 cm1)19,30 is also located in healthy cells on the inner
leaflet of the plasma membrane and forms between 20% and
50% of the membrane composition.31 This peak was evident
after the HeLa cells were treated with auranofin and AE76
(Fig. 2). Phosphatidylethanolamine is co-regulated with
phosphatidylserine and externalized during apoptosis.32,33
This existing relationship between these two phospholipids
could potentially be used for the detection of apoptosis using
Raman spectroscopy. The band at 1720 cm1 was assigned to
carbonyl and ester groups associated with phospholipids,19 an
increase in phospholipids could be due to the formation of
lipid rich vesicles which forms during apoptosis.22 The
decrease in the peak at 733 cm1 together with the prominent
appearance of the peak at 761 cm1 and significant increase in
1720 cm1 appear to be indicative of induced apoptosis.
To summarize; the interpretations of Raman spectroscopy
data allowed for a detailed description of the mechanism of
action of the metallodrugs tested (some metallodrugs were
superior at inducing apoptosis quicker). Changes in vibra-
tional bands assigned to phosphatidylethanolamine were in-
dicative of apoptosis. Confirmatory experiments using other
methodologies are needed to validate this finding, e.g., the
detection of fluorescent anti-phosphatidylethanolamine anti-
bodies using enzyme-linked immunosorbent assay, fluorescent
microscopy, or flow cytometry.32,34 Correlations between
flow cytometric data and Raman spectra was evident in the
detection of indicators of apoptosis. The increase of glucose
peak intensities was also unmistakable and knowing the im-
portant role that this metabolite plays during cancer cell sur-
vival (high levels of glucose consumption involved in
excreting chemotherapy) supports this observation.
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